Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

NCT: NCT07789041 · RECRUITING

NCT IDNCT07789041
StatusRECRUITING
Start Date2025-08-12
Completion2026-12-12
SponsorEndeavor Health (OTHER)
First posted
Last updated

Brief Summary

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑